Contact this trialFirst, we need to learn more about you.
Checkpoint Inhibitor
Combination Immunotherapy + VSV-IFNβ-NIS for Solid Tumors
Recruiting2 awardsPhase 1 & 2
Rochester, Minnesota
This trial is testing a new cancer treatment combination and is designed to find the best dose of the new combination. The study will have three parts: a safety run-in, a dose escalation, and an expansion. The safety run-in will test the new combination on a small group of patients to check for side effects. The dose escalation will test different doses of the new combination on groups of patients to find the best dose. The expansion will test the best dose on a larger group of patients.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.